Egypt’s Prime Minister commits to resolving Egypt’s medicine shortage 

EGYPT— Egypt’s Prime Minister, Mostafa Madbouly, announced on July 18, 2024, that the government aims to resolve the ongoing medicine shortage in Egypt crisis within three months.  

The shortage affects approximately 3,000 types of medications, leaving many pharmacies struggling to meet the needs of patients across the country.

During a press conference, Madbouly reiterated the government’s unwavering commitment to collaborating with the Egyptian Drug Authority (EDA) to restore production levels to normal. 

“We are working closely with the EDA to ensure that the production of essential medicines resumes promptly,” he stated. 

This initiative responds to increasing public concern over the accessibility of vital drugs, which has been exacerbated by a combination of factors, including raw material shortages and logistical delays.

The Prime Minister acknowledged that the devaluation of the Egyptian pound has led to rising prices for some medications. 

“While we strive to increase production, it is important to note that some prices will inevitably rise due to currency fluctuations,” Madbouly explained. 

This economic reality has put additional pressure on consumers and healthcare providers, as many are forced to navigate the complexities of a market where the availability of medicines is inconsistent.

Egypt relies heavily on imports for its pharmaceutical needs, with approximately 90% of the raw materials required for drug production coming from abroad. 

This dependency has posed significant challenges, particularly in light of recent global supply chain disruptions. 

“We must enhance our local production capabilities to reduce reliance on imports and ensure a stable supply of medications,” Madbouly asserted.

The current crisis has affected the availability of medicines and raised concerns about Egypt’s overall healthcare system. 

Patients have reported difficulties in accessing essential treatments, leading to increased anxiety and health risks. 

In response, the government is prioritizing the resumption of production and the efficient release of medicines from ports, which a lack of U.S. dollar liquidity has hindered.

Madbouly’s announcement has been met with cautious optimism among healthcare professionals and patients alike. 

Dr. Ahmed El-Sayed, a prominent pharmacist in Cairo, expressed hope for the government’s initiative. 

“If the government can truly implement these changes within the promised timeframe, it will make a significant difference for many patients who rely on these medications,” he remarked.

In addition to addressing the immediate shortage, Madbouly’s plan includes long-term strategies to enhance the pharmaceutical sector’s resilience. 

This involves increasing local manufacturing capabilities and improving the regulatory framework governing drug production and distribution. 

“We are committed to ensuring that our healthcare system can withstand future challenges,” he added.

As Egypt navigates this critical period, the government’s proactive and comprehensive approach may serve as a turning point for the pharmaceutical industry.

 By addressing both the immediate and underlying issues contributing to the medicine shortage, the Egyptian government aims to restore public confidence in its healthcare system and ensure that essential medications are accessible to all citizens.

Sign up to receive our email newsletters with the latest news updates and insights from Africa and the World HERE